Mark Cuban’s generic drug prices would save Medicare billions of dollars: Harvard study

Medicare recipients could have saved up to $3.6 billion on generic drug costs in 2020 if Medicare paid the same prices as investor Mark Cuban's pharmacy, according to a study published June 20 in Annals of Internal Medicine. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive